Expression of pro- and antiapoptotic proteins in circulating CD8+ T cells of patients with squamous cell carcinoma of the head and neck

Clinical Cancer Research

Volumn 10, Issue 15, 2004, Pages 5101-5110

  Kim, Jeong Whun ^a   Tsukishiro, Takashi ^a   Johnson, Jonas T ^a,b   Whiteside, Theresa L ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; FAS ANTIGEN; LIPOCORTIN 5; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL;

APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEMBRANE POTENTIAL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE;

ADULT; AGED; ANNEXIN A5; ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CARCINOMA, SQUAMOUS CELL; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; COHORT STUDIES; FEMALE; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MEMBRANE POTENTIALS; MIDDLE AGED; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-BCL-2; T-LYMPHOCYTES; TIME FACTORS; UP-REGULATION;

EID: 4143133174     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-0309     Document Type: Article

References (30)

1. Whiteside TL. Immunobiology and immunotherapy of head and neck cancer. Curr Oncol Rep 2001;3:46-55.
2. Reichert TE, Rabinowich H, Johnson JT, Whiteside TL, Human immune cells in the tumor microenvironment: mechanisms responsible for signaling and functional defects. J Immunother 1998;21:295-306.
3. Hoffmann TK, Dworacki G, Tsukihiro T, et al. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin Cancer Res 2002;8:2553-62.
4. Reichert TE, Strauss L, Wagner EM, Gooding W, Whiteside TL. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma. Clin Cancer Res 2000;8:3137-45.
5. dim natural killer cell subset in patients with cancer. Eur J Immunol 2003;33:119-24.
6. Dworacki G, Meidenbauer N, Kuss I, et al. Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma. Clin Cancer Res 2001;7:947s-57s.
7. Saito T, Kuss I, Dworacki Z, Gooding W, Johnson JT, Whiteside TL. Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer Clin Cancer Res 1999;5:1263-73.
8. Whiteside TL. Apoptosis of immune cells in the tumor microenviroment and peripheral circulation of patients with cancer: implications for immunotherapy. Vaccine 2002;20:A46-51.
9. - T cells have signaling defects in patients with squamous cell carcinoma of the head and neck. Br J Cancer 2003;88:223-30.
10. - T-cell subset of effector cells in the circulation of patients with head and neck cancer. Cancer Immunol Immunother 2003;52:599-607.
11. Whiteside TL, Tumor-induced death of immune cells: its mechanisms and consequences. Semin Cancer Biol 2002;12:43-50.
12. Gastman BR, Atarashi Y, Reichert TE, et al. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes. Cancer Res 1999;59:5356-64.
13. Borner C. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol 2003;39:615-47.
14. Rasola A, Geuna MA. Flow cytometry assay simultaneously detects independent apoptotic parameters. Cytometry 2001;45:151-7.
15. Saito T, Dworacki G, Gooding W, Lotze MT, Whiteside TL. Spontaneous apoptosis of CD8+ T lymphocytes in peripheral blood of patients with advanced melanoma. Clin Cancer Res 2000;6:1351-64.
16. Kuss I, Hathaway B, Ferris RL, Gooding W, Whiteside TL. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck. Clin Cancer Res 2004;10:3755-62.
17. Hebib NC, Deas O, Rouleau M, et al. Peripheral blood T cells generated after allogeneic bone marrow transplantation: lower levels of bcl-2 protein and enhanced sensitivity to spontaneous and CD95-mediated apoptosis in vitro. Abrogation of the apoptotic phenotype coincides with the recovery of normal naive/primed T-cell profiles. Blood 1999;94:1803-13.
18. Yuen MF, Hughes RD, Heneghan MA, Langley PG, Norris S. Expression of Fas antigen (CD95) in peripheral blood lymphocytes and in liver-infiltrating, cytotoxic lymphocytes in patients with hepatocellular carcinoma. Cancer (Phila) 2001;92:2136-41.
19. Groneberg C, Pickartz T, Binder A, et al. Clinical relevance of CD95 (Fas/Apo-1) on T cells of patients with B-cell chronic lymphocytic leukemia. Exp Hematol 2003;31:682-5.
20. Massaia M, Borrione P, Attisano C, et al. Dysregulated Fas and Bcl-2 expression leading to enhanced apoptosis in T cells of multiple myeloma patients. Blood 1995;85:3679-87.
21. Smaili SS, Hsu YT, Sanders KM, Russell JT, Youle RJ. Bax translocation to mitochondria subsequent to a rapid loss of mitochondrial membrane potential. Cell Death Differ 2001;8:909-20.
22. Aggarwala S, Gupta S. Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax. J Immunol 1998;160:1627-37.
23. Klatka J, Rolinski J, Kupisz K, Klonowski S, Skomra D. Expression of bcl-2 protein in lymphocytes of patients with laryngeal carcinoma. Eur Arch Otorhinolaryngol 1999;256:299-302.
24. Di Renzo M, Serrano D, Zhou Z, George I, Becker K, Cunningham-Rundles C. Enhanced T cell apoptosis in common variable immunodeficiency: negative role of the fas/fas ligand system and of the Bcl-2 family proteins and possible role of TNF-RS. Clin Exp Immunol 2001;125:117-22.
25. Sharief MK, Douglas M, Noori M, Semra YK. The expression of pro- and anti-apoptosis Bcl-2 family proteins in lymphocytes from patients with multiple sclerosis. J Neuroimmunol 2002;125:155-62.
26. Thomas A, Pepper C, Hoy T, Bentley P. Bcl-2 and bax expression and chlorambucil-induced apoptosis in the T-cells and leukaemic B-cells of untreated B-cell chronic lymphocytic leukaemia patients. Leuk Res 2000;24:813-21.
27. Yokoyama T, Tanahashi M, Kobayashi M, Yamakawa Y, et al. The expression of Bcl-2 family proteins (Bcl-2, Bcl-x, Bax, Bak and Bim) in human lymphocytes. Immunol Lett 2002;81:107-17.
28. Shibuya TY, Nugyen N, McLaren CE, Li K-T, et al. Clinical significance of poor CD3 response in head and neck cancer. Clin Cancer Res 2002;8:745-51.
29. Reichert TE, Day R, Wagner EM, Whiteside TL. Absent of low expression of the ζ chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma. Cancer Res 1998;58:5344-7.
30. Reichert TE, Scheuer C, Day R, Wagner W, Whiteside TL. The number of intratumoral dendritic cells and ζ-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma. Cancer (Phila) 2001;91:2136-47.